Genome-wide association analysis with gray matter volume as a quantitative phenotype in first-episode treatment-naïve patients with schizophrenia
- PMID: 24086445
- PMCID: PMC3782493
- DOI: 10.1371/journal.pone.0075083
Genome-wide association analysis with gray matter volume as a quantitative phenotype in first-episode treatment-naïve patients with schizophrenia
Erratum in
-
Correction: Genome-wide association analysis with gray matter volume as a quantitative phenotype in first-episode treatment-naïve patients with schizophrenia.PLoS One. 2015 Apr 7;10(4):e0122945. doi: 10.1371/journal.pone.0122945. eCollection 2015. PLoS One. 2015. PMID: 25848962 Free PMC article.
Abstract
Reduced Gray matter (GM) volume is a core feature of schizophrenia. Mapping genes that is associated with the heritable disease-related phenotypes may be conducive to elucidate the pathogenesis of schizophrenia. This study aims to identify the common genetic variants that underlie the deficits of GM volume in schizophrenia. High-resolution T1 images and whole genome genotyping data were obtained from 74 first-episode treatment-naïve patients with schizophrenia and 51 healthy controls in the Mental Health Centre of the West China Hospital, Sichuan University. All participants were scanned using a 3T MR imaging system and were genotyped using the HumanHap660 Bead Array. Reduced GM volumes in three brain areas including right hOC3v in the collateral sulcus of visual cortex (hOC3vR), left cerebellar vermis lobule 10 (vermisL10) and right cerebellar vermis lobule 10 (vermisR10) were found in patients with schizophrenia [corrected].There was a group by genotype interaction when genotypes from genome-wide scan were subsequently considered in the case-control analyses. SNPs from three genes or chromosomal regions (TBXAS1, PIK3C2G and HS3ST5) were identified to predict the changes of GM volume in hOC3vL, vermisL10 and vermisR10. These results also highlighted the usefulness of endophenotype in exploring the pathogenesis of neuropsychiatric diseases such as schizophrenia although further independent replication studies are needed in the future.
Conflict of interest statement
Figures



References
-
- van Os J, Kapur S (2009) Schizophrenia. Lancet 374: 635-645. doi:10.1016/S0140-6736(09)60995-8. PubMed: 19700006. - DOI - PubMed
-
- Gottesman II, McGuffin P, Farmer AE (1987) Clinical genetics as clues to the ¡°real¡± genetics of schizophrenia (a decade of modest gains while playing for time). Schizophr Bull 13: 23-47. doi:10.1093/schbul/13.1.23. PubMed: 3474774. - DOI - PubMed
-
- McGuffin P, Gottesman II (1999) Risk factors for schizophrenia. N Engl J Med 341: 370-371; author reply: 372 doi:10.1056/NEJM199907293410513. PubMed: 10428662. - DOI - PubMed
-
- Shi Y, Li Z, Xu Q, Wang T, Li T et al. (2011) Common variants on 8p12 and 1q24.2 confer risk of schizophrenia. Nat Genet 43: 1224-1227. doi:10.1038/ng.980. PubMed: 22037555. - DOI - PMC - PubMed
-
- Yue WH, Wang HF, Sun LD, Tang FL, Liu ZH et al. (2011) Genome-wide association study identifies a susceptibility locus for schizophrenia in Han Chinese at 11p11.2. Nat Genet 43: 1228-1231. doi:10.1038/ng.979. PubMed: 22037552. - DOI - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical